An EMR-based alert helped reduce unnecessary orders for testing for Clostridioides difficile infection in hospitals, according to a study published in Infection Control & Hospital Epidemiology.

Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...

56% Increase in C. diff Due in Part to Improved Detection Hospitals that switched Clostridium difficile testing from nonmolecular to molecular methods recorded a 56 percent increase in recorded C.

A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...

Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced. “The Clarity toxin A/B assay offers a new approach to testing for C. diff ...

Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.

After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior. Through a series of interventions ...

A differential blood count is a blood test to check your white blood cell levels, which can indicate the presence of infection, disease, or an allergic reaction. Your doctor might order it as part of ...